Related Experiment Videos
Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
L B Heifets1, P J Lindholm-Levy
1National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.
The American Review of Respiratory Disease
|January 1, 1990
Summary
Pyrazinamide (PZA) shows limited bactericidal activity against Mycobacterium tuberculosis in vitro, even at high concentrations. This suggests PZA
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Pyrazinamide (PZA) is a crucial first-line antituberculosis drug.
- Its clinical efficacy suggests potent sterilizing activity.
- In vitro bactericidal mechanisms remain incompletely understood.
Purpose of the Study:
- To evaluate the in vitro bactericidal activity of PZA against drug-susceptible Mycobacterium tuberculosis.
- To compare PZA's in vitro performance with other antituberculosis agents.
Main Methods:
- Testing PZA bactericidal activity in 7H12 broth at pH 5.6.
- Utilizing drug-susceptible Mycobacterium tuberculosis strains.
- Assessing bacterial kill at concentrations up to 1,000 micrograms/ml.
Main Results:
- High PZA concentrations (500-1,000 µg/ml) killed no more than 76% of bacteria.
- Tested concentrations exceeded the minimal inhibitory concentration (MIC) and in vivo achievable levels.
- PZA demonstrated significantly less in vitro bactericidal activity compared to other antituberculosis drugs.
Conclusions:
- PZA's in vitro bactericidal activity is notably lower than expected based on clinical data.
- The study highlights a discrepancy between PZA's in vitro and in vivo efficacy.
- Further research is needed to elucidate PZA's mechanism of action and sterilizing effect.